About Felix Pharmaceuticals Private Limited
Data last updated:
Felix Pharmaceuticals Private Limited was a private limited company based in Kolkata, West Bengal, India, operated as a subsidiary of Piyanshu Chemicals Pvt Ltd. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 February 2006.
The company was registered with the Registrar of Companies (ROC), Kolkata, under CIN U24231WB2006PTC256797.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4 Lakh. It was led by directors Padmanabh Bhagat and Satyabodh Bhagat.
Its last annual general meeting (AGM) was held on 24 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at 53A Tiljala Road Mescab Center 4th Floor, Kolkata, West Bengal, India – 700046.
As per the financials filed for FY 2022, the company reported a revenue of ₹8.74 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹5.08 Lakh (net margin 58.1%) and EBITDA of ₹7.33 Lakh (EBITDA margin 83.9%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 3% over five years.
The company was associated with 1 brand: Felixvet.
The last known website on record is felixpharma.com.
Company details
CIN history
Felix Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24231WB2006PTC256797, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231WB2006PTC256797 | Current |
| U24231AP2006PTC049035 | Previous |
| U24231TG2006PTC049035 | Previous |
Contact details
Felix Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address53A Tiljala Road Mescab Center 4th Floor, Kolkata, West Bengal, India – 700046
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Felix Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Felix Pharmaceuticals operates one associated brand: Felixvet. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generic and complex veterinary pharmaceuticals are manufactured for companion animals. | felixvet.com |
Financials of Felix Pharmaceuticals Private Limited
FY 2022 filings availableFelix Pharmaceuticals Private Limited reported revenue of ₹8.74 Lakh (down 2% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 2% fall in the latest year. EBITDA rose 101% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹8.74 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 83.9% | ||||
| Net Profit Margin | 58.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Felix Pharmaceuticals Private Limited, buy the company report.
Board of directors of Felix Pharmaceuticals Private Limited
Felix Pharmaceuticals has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Padmanabh Bhagat Also directs: Piyanshu Chemicals Pvt Ltd | Director | 06 May 2017 | 9 Years 5 Months | As last reported |
| Satyabodh Bhagat Also directs: Piyanshu Chemicals Pvt Ltd, Ishan Resins & Paints Limited | Director | 06 May 2017 | 9 Years 5 Months | As last reported |
Peer comparison
Felix Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genastro Pharmaceuticals Private Limited | ₹8.78 Lakh (FY 2025) | 41.0% | Delhi, India | |||
| Sotac Research Private Limited | ₹8.78 Lakh (FY 2025) | 123.0% | Ahmedabad, Gujarat, India | |||
| Ealder Pharmaceuticals Private Limited | ₹8.78 Lakh (FY 2023) | 21.0% | Ashiana Nagar, Bihar, India | |||
| Groove Pharmaceuticals Private Limited | ₹8.75 Lakh (FY 2024) | -27.0% | Mandir, Chembur (W), Maharashtra, India | |||
| Gracrux Pharmaceuticals Private Limited | ₹8.74 Lakh (FY 2025) | 198.0% | Mumbai, Maharashtra, India | |||
| Felix Pharmaceuticals Private Limitedthis company | ₹8.74 Lakh (FY 2022) | ₹5.08 Lakh | 58.1% | -2.0% | Kolkata, West Bengal, India | |
| Nordisk Pharmaceuticals Private Limited | ₹8.73 Lakh (FY 2023) | 16.0% | Rewa, Madhya Pradesh, India | |||
| Essence Pharmaceuticals Private Limited | ₹8.71 Lakh (FY 2016) | -53.0% | New Delhi, Delhi, India | |||
| Glowchem Pharmaceuticals Private Limited | ₹8.7 Lakh (FY 2016) | 10.0% | Gopalganj, Bihar, India | |||
| MBM Pharmaceuticals Private Limited | ₹8.7 Lakh (FY 2025) | 32.0% | Akola, Maharashtra, India | |||
| Domcain Pharmaceuticals Private Limited | ₹8.69 Lakh (FY 2025) | 9.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Felix Pharmaceuticals Private Limited, buy the company report.
Auditor
Felix Pharmaceuticals Private Limited is audited by G A R V & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G A R V & Associates | FY 2022 | 301094E |
Shareholding
The shareholding of Felix Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Felix Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Felix Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Felix Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Felix Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Felix Pharmaceuticals Private Limited has 14 board changes on record since 2008: 2 appointments and 12 cessations. The latest: Satyabodh Bhagat ceased to be Additional Director on 23 Sep 2017.
5 earlier events are in the company report.
Frequently asked questions
Felix Pharmaceuticals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Felix Pharmaceuticals was a private limited company based in Kolkata, West Bengal, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 06 February 2006 and is registered under CIN U24231WB2006PTC256797. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Felix Pharmaceuticals was incorporated on 06 February 2006. It is registered with the Registrar of Companies, Kolkata.
Felix Pharmaceuticals had 2 directors:
- Padmanabh Bhagat - Director
- Satyabodh Bhagat - Director
The CIN (Corporate Identification Number) of Felix Pharmaceuticals is U24231WB2006PTC256797. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Felix Pharmaceuticals is at 53A Tiljala Road Mescab Center 4th Floor, Kolkata, West Bengal, India – 700046.
Felix Pharmaceuticals can be reached through the website felixpharma.com. Its registered office is in Kolkata, West Bengal, India.
The latest financial statements of Felix Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 24 September 2022. Year-wise statements from 2015 are in the company report.
Felix Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment.
The peers of Felix Pharmaceuticals by revenue are Genastro Pharmaceuticals Private Limited, Sotac Research Private Limited, Ealder Pharmaceuticals Private Limited, Groove Pharmaceuticals Private Limited, Gracrux Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Satyabodh Bhagat ceased to be Additional Director on 23 Sep 2017. Manjari Bhagat ceased to be Director on 20 May 2017. Rahul Jajodia ceased to be Director on 20 May 2017. Felix Pharmaceuticals has 14 board changes on record in total.